title: Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma?
authors.affiliation: Departments of Oncology and Medicine, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. George.K.Philips@gunet.georgetown.edu
authors.forename: George
authors.initials: G
authors.lastname: Philips
authors.forename: Michael B
authors.initials: MB
authors.lastname: Atkins
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2